CRC cells treated with SN38 in combination with QNZ showed restricted OPN, survivin, and ISG15 in QNZ-mediated NF-κB inhibition but not with Bay, suggesting the involvement of non-canonical NF-κB signaling (Figure 4F). The gene discussed is NFKB1; the disease is colorectal carcinoma.